Picture of 4DMedical logo

4DX — 4DMedical Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Momentum

Relative Strength (%)
1m0%
3m-21.11%
6m-50.83%
1yr-47.8%
Volume Change (%)
10d/3m+150.52%
Price vs... (%)
52w High-67.34%
50d MA-3.83%
200d MA-42.66%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-28.73%
Return on Equity-34.9%
Operating Margin-9292.99%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202230th Jun 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of 4DMedical EPS forecast chart

Profile Summary

4DMedical Limited is an Australia-based medical technology company focused on delivering respiratory diagnostics for all lung disorders, including coronavirus, asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis and cancer. The Company's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The Company's software enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

Directors

Last Annual
June 30th, 2021
Last Interim
December 31st, 2021
Incorporated
December 17th, 2012
Public Since
June 1st, 1988
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
294,491,837
Blurred out image of a map
Address
5/468 St. Kilda Road, MELBOURNE, 3004
Web
https://4dmedical.com/
Phone
+61 395455940
Contact
Simon Hinsley
Auditors
PKF Melbourne Audit & Assurance Pty Ltd

4DX Share Price Performance

Upcoming Events for 4DX

Full Year 2022 4DMedical Ltd Earnings Release

4DMedical Ltd Annual Shareholders Meeting

Similar to 4DX

Picture of Adherium logo

Adherium

au flag iconAustralian Stock Exchange - SEATS

Picture of Allegra Orthopaedics logo

Allegra Orthopaedics

au flag iconAustralian Stock Exchange - SEATS

Picture of Analytica logo

Analytica

au flag iconAustralian Stock Exchange - SEATS

Picture of Ansell logo

Ansell

au flag iconAustralian Stock Exchange - SEATS

Picture of Anteris Technologies logo

Anteris Technologies

au flag iconAustralian Stock Exchange - SEATS

FAQ

Or unlock with your email

Or unlock with your email